Income Statement Masimo Corporation
Equities
MASI
US5747951003
Medical Equipment, Supplies & Distribution
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
169.45 USD | -2.14% | -0.27% | +2.53% |
Jan. 22 | The rise of oligarchy? | |
Jan. 21 | Masimo Names Former Becton Dickinson Executive as CEO, Katie Szyman Takes Over for Board Chair Michelle Brennan | MT |
Fiscal Period: December | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Revenues | 938M | 1.14B | 1.24B | 2.04B | 2.05B | |||||
Total Revenues | 938M | 1.14B | 1.24B | 2.04B | 2.05B | |||||
Cost of Goods Sold, Total | 309M | 401M | 431M | 977M | 1.04B | |||||
Gross Profit | 629M | 743M | 808M | 1.06B | 1B | |||||
Selling General & Admin Expenses, Total | 315M | 369M | 395M | 641M | 682M | |||||
R&D Expenses | 93.3M | 119M | 137M | 191M | 175M | |||||
Other Operating Expenses, Total | 408M | 488M | 533M | 832M | 857M | |||||
Operating Income | 221M | 255M | 276M | 227M | 147M | |||||
Interest Expense, Total | -328K | -338K | -355K | -25.7M | -50.3M | |||||
Interest And Investment Income | 13.92M | 5.53M | 936K | 1.8M | 3M | |||||
Net Interest Expenses | 13.59M | 5.2M | 581K | -23.9M | -47.3M | |||||
Currency Exchange Gains (Loss) | -627K | 2.63M | -1.86M | 7.3M | -1.1M | |||||
Other Non Operating Income (Expenses) | -12K | 86K | -160K | - | - | |||||
EBT, Excl. Unusual Items | 234M | 263M | 274M | 210M | 98.3M | |||||
Merger & Related Restructuring Charges | - | - | - | -16.6M | - | |||||
Gain (Loss) On Sale Of Assets | - | - | - | - | - | |||||
Asset Writedown | - | - | - | - | -10M | |||||
Insurance Settlements | - | - | - | - | 17.6M | |||||
Legal Settlements | - | 474K | - | - | -17.8M | |||||
EBT, Incl. Unusual Items | 234M | 264M | 274M | 193M | 88.1M | |||||
Income Tax Expense | 37.95M | 23.45M | 44.73M | 49.9M | 6.6M | |||||
Earnings From Continuing Operations | 196M | 240M | 230M | 144M | 81.5M | |||||
Net Income to Company | 196M | 240M | 230M | 144M | 81.5M | |||||
Minority Interest | - | 20K | - | - | - | |||||
Net Income - (IS) | 196M | 240M | 230M | 144M | 81.5M | |||||
Net Income to Common Incl Extra Items | 196M | 240M | 230M | 144M | 81.5M | |||||
Net Income to Common Excl. Extra Items | 196M | 240M | 230M | 144M | 81.5M | |||||
Per Share Items | ||||||||||
Net EPS - Basic | 3.67 | 4.39 | 4.16 | 2.68 | 1.54 | |||||
Basic EPS - Continuing Operations | 3.67 | 4.39 | 4.16 | 2.68 | 1.54 | |||||
Basic Weighted Average Shares Outstanding | 53.43M | 54.7M | 55.17M | 53.6M | 52.8M | |||||
Net EPS - Diluted | 3.44 | 4.14 | 3.98 | 2.6 | 1.51 | |||||
Diluted EPS - Continuing Operations | 3.44 | 4.14 | 3.98 | 2.6 | 1.51 | |||||
Diluted Weighted Average Shares Outstanding | 57.1M | 58.04M | 57.68M | 55.2M | 54.1M | |||||
Normalized Basic EPS | 2.74 | 3.01 | 3.11 | 2.45 | 1.16 | |||||
Normalized Diluted EPS | 2.56 | 2.84 | 2.97 | 2.38 | 1.14 | |||||
Supplemental Items | ||||||||||
EBITDA | 245M | 285M | 311M | 358M | 226M | |||||
EBITA | 226M | 263M | 286M | 266M | 201M | |||||
EBIT | 221M | 255M | 276M | 227M | 147M | |||||
EBITDAR | 251M | 292M | 320M | 376M | 248M | |||||
Total Revenues (As Reported) | 938M | 1.14B | 1.24B | - | - | |||||
Effective Tax Rate - (Ratio) | 16.21 | 8.89 | 16.3 | 25.8 | 7.49 | |||||
Current Domestic Taxes | 35.49M | 20.34M | 45.24M | 54.8M | 18.5M | |||||
Current Foreign Taxes | 8.42M | 8.07M | 14.58M | 34.4M | 23.7M | |||||
Total Current Taxes | 43.92M | 28.42M | 59.82M | 89.2M | 42.2M | |||||
Deferred Domestic Taxes | -5.72M | -4.84M | -10.94M | -29.2M | -21.5M | |||||
Deferred Foreign Taxes | -248K | -127K | -4.15M | -10.1M | -14.1M | |||||
Total Deferred Taxes | -5.96M | -4.96M | -15.09M | -39.3M | -35.6M | |||||
Normalized Net Income | 146M | 165M | 171M | 131M | 61.44M | |||||
Interest Capitalized | - | - | - | - | - | |||||
Interest on Long-Term Debt | 300K | 300K | 300K | 25.7M | 47M | |||||
Non-Cash Pension Expense | - | - | - | -100K | -200K | |||||
Supplemental Operating Expense Items | ||||||||||
Advertising Expense | 14M | 30.8M | 9M | 12.3M | 61.4M | |||||
Selling and Marketing Expenses | 14M | 30.8M | 9M | 12.3M | 61.4M | |||||
Research And Development Expense From Footnotes | 93.3M | 119M | 137M | 191M | 350M | |||||
Net Rental Expense, Total | 6.57M | 6.95M | 8.2M | 18M | 22.7M | |||||
Imputed Operating Lease Interest Expense | - | 685K | 695K | 6.97M | 9.14M | |||||
Imputed Operating Lease Depreciation | - | 6.26M | 7.5M | 11.03M | 13.56M | |||||
Stock-Based Comp., COGS (Total) | 445K | 714K | 839K | 1M | 1.1M | |||||
Stock-Based Comp., R&D Exp. (Total) | 8.34M | 10.05M | 12.47M | 13.8M | 7.4M | |||||
Stock-Based Comp., SG&A Exp. (Total) | 30.45M | 31.46M | 31.32M | 32.9M | -1.5M | |||||
Total Stock-Based Compensation | 39.24M | 42.22M | 44.62M | 47.7M | 7M |